FDA approves drug to ease menopause symptoms

The latest stories trending on MedCity News.

Editor's Pick

Top Story FDA Approves First-Of-Its Kind Drug to Ease Menopause Symptoms Astellas Pharma won FDA approval for Veozah, a new menopause drug. The once-daily pill offers a new non-hormonal treatment option for addressing menopausal symptoms. Sponsored Content Webinar: Bringing eCommerce Best Practices to Healthcare to Attract and Retain Patients Presented by DexCare and MedCity News Don't miss this upcoming webinar on May 19th! The panelists will focus on how health systems are taking lessons learned from online retailers, and emerging technologies, to attract and convert consumers. Click to register today!

Featured News

The Right Balance of Conversational AI and Human Support Makes the Most Impact on Health System Patients, Staff and Business On the surface, it sounds like one of the simplest procedures undertaken at a health system: answering the phone. But anyone who works at a health system knows it is not that simple. Emerging Investigators Are Pivotal for Meeting Current, Future Drug Development Needs We must engage, train and support more physicians as investigators to enable the opportunity for their patients to have access to clinical trials. As an industry, we should be adding anywhere from 10% to 20% new investigators every year to meet the patient access needs for clinical trials. How AI Will Change the Way Patients Get Medication There is a huge opportunity for PBMs and health systems to use AI to help address the challenges surrounding the affordability and accessibility of medicines, from navigating formularies to resolving prior authorization. More automation in pharmacies and with ordering workflows is one piece of that puzzle. How Payers Can Cut Through the Noise and Optimize Their PBM Partnerships As payers work to optimize their PBM partnerships, the complexity of their agreements makes it important to increase the understanding and apply best practices to ensure transparency and value. Prioritizing the PBM relationship is critical for payers to provide competitive, cost-effective pharmacy benefits.  Report: 22.2M Women Could Lose Access To Free Mammogram Screenings A recent court decision could lead to women losing access to free mammogram screenings, a new Urban Institute report showed. Without insurance, mammograms can cost up to $560 in out-of-pocket expenses.

Resources

Free eBook: "AI in Healthcare: Scratching the Surface" Learn how AI is transforming the healthcare industry and the pitfalls that also exist with its early adoption. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe